Tapering immunosuppression in recipients of living donor kidney transplants

Nephrology Dialysis Transplantation

Volumn 19, Issue SUPPL. 4, 2004, Pages

  Weimar, Willem ^a   Rischen Vos, Jacqueline ^a   de Kuiper, Petronella ^a   Smak Gregoor, Peter J H ^a   IJzermans, Jan N M ^a   van Besouw, Nicole M ^a   Baan, Carla C ^a   van der Mast, Barbara J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cytotoxic T lymphocytes; Immunosuppression; Kidney transplantation

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ARTICLE; CELL ASSAY; CELL SPECIFICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DRUG SAFETY; FREQUENCY ANALYSIS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; STEM CELL;

CELLS, CULTURED; DOWN-REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; PROSPECTIVE STUDIES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 4344627132     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh1044     Document Type: Article

References (7)

1. Soulillou JP, Giral M. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation 2001; 72 [12 Suppl]: S89-S93
2. Smak Gregoor PJH, Gelder van T, Besouw van NM, Mast van der BJ, IJzermans JNM, Weimar W. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction. Transplantation 2000; 70: 3-5
3. Besouw van NM, Mast van der BJ, Kuiper de P et al. Donor-specific t-cell reactivitity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 2000; 70: 136-143
4. Besouw van NM, Mast van der BJ, Kuiper de P et al. Down-regulated donor-specific T-cell reactivity during succesful tapering of immunosuppression after kidney transplantation. Clin Exp Immunol 2002; 128: 388-393
5. Strijbosch LWG, Buurman WA, Does RJMM, Zinken PH, Groenewegen G. Limiting dilution analysis: experimental design and statistical analysis. J Immunol Methods 1987; 97: 133
6. Land W. Mycophenolate mofetil monotherapy in patients who have had kidney transplants. Transplantation 2003; 75: 2159
7. Starzl TE, Murase N, Abu-Elmagd K et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361: 1489-1490